The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
8d
Medical Device Network on MSNFDA tags Medtronic embolisation device recall as Class IMedtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as Class I following reports of four patient deaths. A Class I recall is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results